• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Dr. Mark P. Tyrrell, Specialist Consultant in Dementia
Dr. Mark P. Tyrrell, Specialist Consultant in Dementia

Disease vs illness
Disease vs illness

Parkinson’s Disease (PD)
Parkinson’s Disease (PD)

Use of Yokukansan (TJ-54) in the treatment of neurological
Use of Yokukansan (TJ-54) in the treatment of neurological

Behavioral and psychological disturbances in Alzheimer disease
Behavioral and psychological disturbances in Alzheimer disease

Genetic Analysis in Human Disease
Genetic Analysis in Human Disease

Psychosis in PD
Psychosis in PD

Meniere`s Disease - Neurology Section
Meniere`s Disease - Neurology Section

PDF
PDF

Symposia Saturday, 31 May Symp1-2 Post-stroke dementia
Symposia Saturday, 31 May Symp1-2 Post-stroke dementia

Investigation of pathological mechanisms underlying the childhood
Investigation of pathological mechanisms underlying the childhood

disease detectives test
disease detectives test

... 23. Which of these is an example of temporality? a. observations of an association between risk factors and the disease are found in more than one population b. the suspected cause occurs before the effect c. the suggested hypothesis is biologically plausible d. increasing risk responds with increas ...
Intro To Community Demtistry
Intro To Community Demtistry

Sample Size Estimation Incorporating Disease Progression
Sample Size Estimation Incorporating Disease Progression

Peripheral Vascular Disease Peripheral Vascular Disease
Peripheral Vascular Disease Peripheral Vascular Disease

Is not a normal process of aging
Is not a normal process of aging

Mareks Disease - WordPress.com
Mareks Disease - WordPress.com

What Every Occupational Therapist Should Know About Progressive
What Every Occupational Therapist Should Know About Progressive

Slide 1
Slide 1

Title Here (36
Title Here (36

Pellagra encephalopathy as a differential diagnosis for Creutzfeldt
Pellagra encephalopathy as a differential diagnosis for Creutzfeldt

... to further clinical deterioration before the typical triad (i.e. dermatitis and diarrhoea in addition to dementia) of pellagra could be recognized (Serdaru et al. 1988). Niacin deficiency may lead to neuropsychiatric symptoms due to relative serotonin deficiency, moreover, the decreased kynurenic ac ...
Creutzfeldt-Jakob Disease: A Case Report”. Journal of Evidence
Creutzfeldt-Jakob Disease: A Case Report”. Journal of Evidence

Tests used in diagnosing dementia
Tests used in diagnosing dementia

Psychiatric DOs
Psychiatric DOs

Molecular neurology Parkinson`s disease
Molecular neurology Parkinson`s disease

< 1 ... 31 32 33 34 35 36 37 38 39 ... 47 >

Alzheimer's disease



Alzheimer's disease (AD), also known as Alzheimer disease, or just Alzheimer's, accounts for 60% to 70% of cases of dementia. It is a chronic neurodegenerative disease that usually starts slowly and gets worse over time. The most common early symptom is difficulty in remembering recent events (short-term memory loss). As the disease advances, symptoms can include problems with language, disorientation (including easily getting lost), mood swings, loss of motivation, not managing self care, and behavioural issues. As a person's condition declines, they often withdraw from family and society. Gradually, bodily functions are lost, ultimately leading to death. Although the speed of progression can vary, the average life expectancy following diagnosis is three to nine years.The cause of Alzheimer's disease is poorly understood. About 70% of the risk is believed to be genetic with many genes usually involved. Other risk factors include a history of head injuries, depression, or hypertension. The disease process is associated with plaques and tangles in the brain. A probable diagnosis is based on the history of the illness and cognitive testing with medical imaging and blood tests to rule out other possible causes. Initial symptoms are often mistaken for normal ageing. Examination of brain tissue is needed for a definite diagnosis. Mental and physical exercise, and avoiding obesity may decrease the risk of AD. There are no medications or supplements that decrease risk.No treatments stop or reverse its progression, though some may temporarily improve symptoms. Affected people increasingly rely on others for assistance, often placing a burden on the caregiver; the pressures can include social, psychological, physical, and economic elements. Exercise programs are beneficial with respect to activities of daily living and can potentially improve outcomes. Treatment of behavioral problems or psychosis due to dementia with antipsychotics is common but not usually recommended due to there often being little benefit and an increased risk of early death.In 2010, there were between 21 and 35 million people worldwide with AD. It most often begins in people over 65 years of age, although 4% to 5% of cases are early-onset Alzheimer's which begin before this. It affects about 6% of people 65 years and older. In 2010, dementia resulted in about 486,000 deaths. It was first described by, and later named after, German psychiatrist and pathologist Alois Alzheimer in 1906. In developed countries, AD is one of the most financially costly diseases.
  • studyres.com © 2026
  • DMCA
  • Privacy
  • Terms
  • Report